124 related articles for article (PubMed ID: 323739)
1. Effect of nandrolone decanoate on the anemia of chronic hemodialysis patients.
Buchwald D; Argyres S; Easterling RE; Oelshlegel FJ; Brewer GJ; Schoomaker EB; Abbrecht PH; Williams GW; Weller JM
Nephron; 1977; 18(4):232-8. PubMed ID: 323739
[No Abstract] [Full Text] [Related]
2. Nandrolone decanoate therapy for patients receiving hemodialysis. A controlled study.
Williams JS; Stein JH; Ferris TF
Arch Intern Med; 1974 Aug; 134(2):289-92. PubMed ID: 4602048
[No Abstract] [Full Text] [Related]
3. Controlled study of androgen therapy in anemia of patients on maintenance hemodialysis.
Hendler ED; Goffinet JA; Ross S; Longnecker RE; Bakovic V
N Engl J Med; 1974 Nov; 291(20):1046-51. PubMed ID: 4606387
[No Abstract] [Full Text] [Related]
4. The effects of nandrolone decanoate on nutritional parameters in hemodialysis patients.
Barton Pai A; Chretien C; Lau AH
Clin Nephrol; 2002 Jul; 58(1):38-46. PubMed ID: 12141405
[TBL] [Abstract][Full Text] [Related]
5. The role of nandrolone decanoate in patients with end stage renal disease in the erythropoietin era.
Johansen KL
Int J Artif Organs; 2001 Apr; 24(4):183-5. PubMed ID: 11394696
[No Abstract] [Full Text] [Related]
6. Androgen therapy for anaemia of chronic renal failure. Indications in the erythropoietin era.
Teruel JL; Aguilera A; Marcen R; Navarro Antolin J; Garcia Otero G; Ortuño J
Scand J Urol Nephrol; 1996 Oct; 30(5):403-8. PubMed ID: 8936631
[TBL] [Abstract][Full Text] [Related]
7. Randomized prospective comparison between erythropoietin and androgens in CAPD patients.
Navarro JF; Mora C; Macía M; García J
Kidney Int; 2002 Apr; 61(4):1537-44. PubMed ID: 11918762
[TBL] [Abstract][Full Text] [Related]
8. Nandrolone decanoate reduces serum lipoprotein(a) concentrations in hemodialysis patients.
Teruel JL; Lasuncion MA; Rivera M; Aguilera A; Ortega H; Tato A; Marcen R; Ortuño J
Am J Kidney Dis; 1997 Apr; 29(4):569-75. PubMed ID: 9100047
[TBL] [Abstract][Full Text] [Related]
9. Androgens potentiate the effects of erythropoietin in the treatment of anemia of end-stage renal disease.
Ballal SH; Domoto DT; Polack DC; Marciulonis P; Martin KJ
Am J Kidney Dis; 1991 Jan; 17(1):29-33. PubMed ID: 1986567
[TBL] [Abstract][Full Text] [Related]
10. A controlled trial of recombinant human erythropoietin and nandrolone decanoate in the treatment of anemia in patients on chronic hemodialysis.
Berns JS; Rudnick MR; Cohen RM
Clin Nephrol; 1992 May; 37(5):264-7. PubMed ID: 1606777
[TBL] [Abstract][Full Text] [Related]
11. Androgens for the treatment of anemia in peritoneal dialysis patients.
Navarro JF; Mora-Fernández C; Rivero A; Macía M; Gallego E; Chahin J; Méndez ML; García J
Adv Perit Dial; 1998; 14():232-5. PubMed ID: 10649731
[TBL] [Abstract][Full Text] [Related]
12. Nandrolone decanoate is a good alternative for the treatment of anemia in elderly male patients on hemodialysis.
Gascón A; Belvis JJ; Berisa F; Iglesias E; Estopiñán V; Teruel JL
Geriatr Nephrol Urol; 1999; 9(2):67-72. PubMed ID: 10518249
[TBL] [Abstract][Full Text] [Related]
13. [19-norandrostenolone undecylate in the treatment of anemia in patients treated with periodic hemodialysis].
Docci D; Feliciangeli G; Mosconi G; Vangelista A; Stefoni S
G Clin Med; 1981 Aug; 62(8):567-75. PubMed ID: 7308639
[No Abstract] [Full Text] [Related]
14. Response of uremic patients to nandrolone decanoate.
Doane BD; Fried W; Schwartz F
Arch Intern Med; 1975 Jul; 135(7):972-5. PubMed ID: 1156056
[TBL] [Abstract][Full Text] [Related]
15. Plasma erythropoietin levels in patients undergoing long-term hemodialysis.
Raich PC; Korst DR
Arch Pathol Lab Med; 1978 Feb; 102(2):73-5. PubMed ID: 579968
[TBL] [Abstract][Full Text] [Related]
16. Nandrolone decanoate therapy for anemia in patients on haemodialysis.
Balaji HD; Hariharan S; Jacob CK; Kirubakaran MG; Shastry JC
J Assoc Physicians India; 1988 Nov; 36(11):677-8. PubMed ID: 3074079
[No Abstract] [Full Text] [Related]
17. Androgen trial in renal anaemia.
Naik RB; Gibbons AR; Gyde OH; Harris BR; Robinson BH
Proc Eur Dial Transplant Assoc; 1978; 15():136-43. PubMed ID: 368770
[TBL] [Abstract][Full Text] [Related]
18. Nandrolone decanoate for the treatment of erythropoietin refractory anemia: a case series.
Chawla B; Iqbal FM; Chawla MS
Compr Ther; 2009; 35(3-4):199-203. PubMed ID: 20043618
[TBL] [Abstract][Full Text] [Related]
19. Evolution of serum erythropoietin after androgen administration to hemodialysis patients: a prospective study.
Teruel JL; Marcén R; Navarro JF; Villafruela JJ; Fernández Lucas M; Liaño F; Ortuño J
Nephron; 1995; 70(3):282-6. PubMed ID: 7477614
[TBL] [Abstract][Full Text] [Related]
20. Use of nandrolone decanoate as an adjuvant for erythropoietin dose reduction in treating anemia in patients on hemodialysis.
Sheashaa H; Abdel-Razek W; El-Husseini A; Selim A; Hassan N; Abbas T; El-Askalani H; Sobh M
Nephron Clin Pract; 2005; 99(4):c102-6. PubMed ID: 15703460
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
